X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (329) 329
index medicus (326) 326
oncology (316) 316
colorectal cancer (283) 283
cetuximab (220) 220
anti-egfr therapy (210) 210
cancer (165) 165
chemotherapy (152) 152
anti-egfr (141) 141
mutation (131) 131
female (121) 121
panitumumab (120) 120
colorectal neoplasms - drug therapy (119) 119
colorectal neoplasms - genetics (116) 116
metastasis (111) 111
receptor, epidermal growth factor - antagonists & inhibitors (111) 111
kras (108) 108
1st-line treatment (104) 104
growth-factor receptor (100) 100
antineoplastic agents - therapeutic use (99) 99
care and treatment (99) 99
male (97) 97
colorectal neoplasms - pathology (96) 96
acquired-resistance (84) 84
epidermal growth factor (84) 84
animals (81) 81
middle aged (81) 81
tumors (80) 80
aged (79) 79
anti-egfr antibody (74) 74
antibodies, monoclonal - therapeutic use (74) 74
monoclonal antibodies (72) 72
metastatic colorectal cancer (67) 67
prognosis (63) 63
egfr (62) 62
adult (61) 61
pharmacology & pharmacy (60) 60
genetic aspects (58) 58
analysis (57) 57
braf (57) 57
cell line, tumor (57) 57
therapy (57) 57
cell lung-cancer (54) 54
cancer therapies (53) 53
cetuximab plus irinotecan (51) 51
colorectal carcinoma (51) 51
open-label (51) 51
antineoplastic combined chemotherapy protocols - therapeutic use (50) 50
neoplasm metastasis (50) 50
research (50) 50
health aspects (49) 49
bevacizumab (48) 48
colorectal-cancer (48) 48
medicine & public health (47) 47
ras mutations (47) 47
metastatic colorectal-cancer (46) 46
receptor, epidermal growth factor - immunology (46) 46
phase-iii trial (45) 45
ras proteins - genetics (45) 45
targeted therapy (45) 45
digestive system diseases (44) 44
receptor, epidermal growth factor - metabolism (44) 44
fluorouracil (43) 43
resistance (43) 43
epidermal growth factor receptors (42) 42
proto-oncogene proteins p21 - genetics (42) 42
aged, 80 and over (41) 41
expression (41) 41
hematology, oncology and palliative medicine (41) 41
proto-oncogene proteins b-raf - genetics (41) 41
treatment outcome (41) 41
colon-cancer (40) 40
molecular targeted therapy (40) 40
monoclonal-antibody (40) 40
kras mutations (39) 39
metastases (39) 39
survival (39) 39
antineoplastic agents - pharmacology (38) 38
drug therapy (38) 38
mutations (38) 38
antibodies, monoclonal, humanized (37) 37
biomarkers (37) 37
cell biology (37) 37
mice (37) 37
patients (37) 37
kinases (36) 36
development and progression (35) 35
medicine (35) 35
neoplasms (35) 35
pathology (35) 35
antibodies (34) 34
antibodies, monoclonal - administration & dosage (34) 34
article (34) 34
proto-oncogene proteins - genetics (34) 34
biomarkers, tumor - genetics (33) 33
lung-cancer (33) 33
ras (33) 33
review (33) 33
anti-egfr monoclonal antibodies (32) 32
disease-free survival (32) 32
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (588) 588
French (45) 45
German (8) 8
Spanish (6) 6
Japanese (4) 4
Czech (3) 3
Russian (3) 3
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of oncology, ISSN 0923-7534, 2016, Volume 27, Issue 8, pp. 1386 - 1422
Journal Article
Annals of Oncology, ISSN 0923-7534, 01/2018, Volume 29, Issue 1, pp. 145 - 153
Abstract Background Selection of resistance mutations may play a major role in the development of endocrine resistance. ESR1 mutations are rare in primary... 
Breast cancer | KRAS | ESR1 | ctDNA | ONCOLOGY | CLONAL HEMATOPOIESIS | COLORECTAL-CANCER | breast cancer | ANTI-EGFR THERAPY | MUTATIONS | ESTROGEN-RECEPTOR
Journal Article
Molecular Oncology, ISSN 1574-7891, 09/2014, Volume 8, Issue 6, pp. 1084 - 1094
Cetuximab and panitumumab are anti-epidermal growth factor receptor (anti-EGFR) monoclonal antibodies used as therapies for metastatic colorectal cancer... 
Acquired resistance | RAS | Panitumumab | Colorectal cancer | Cetuximab | Anti-EGFR therapy | MET
Journal Article
Annals of Oncology, ISSN 0923-7534, 01/2018, Volume 29, Issue 1, pp. 112 - 118
Abstract Background Liquid biopsy is an alternative to tissue for RAS testing in metastatic colorectal carcinoma (mCRC) patients. Little information is... 
Liquid biopsy | NRAS | Anti-EGFR monoclonal antibodies | KRAS | Colon carcinoma | HETEROGENEITY | colon carcinoma | PIK3CA MUTATIONS | THERAPY | ONCOLOGY | DNA | BRAF | anti-EGFR monoclonal antibodies | liquid biopsy
Journal Article
Nature Reviews Genetics, ISSN 1471-0056, 02/2019, Volume 20, Issue 2, pp. 71 - 88
Precision oncology seeks to leverage molecular information about cancer to improve patient outcomes. Tissue biopsy samples are widely used to characterize... 
STRANDED-DNA | LUNG-CANCER | CIRCULATING TUMOR-CELLS | DNA LIBRARY PREPARATION | CLINICAL-APPLICATIONS | METASTATIC BREAST-CANCER | PLASMA DNA | GENETICS & HEREDITY | ACQUIRED-RESISTANCE | ANTI-EGFR THERAPY | RESISTANT PROSTATE-CANCER | Disease resistance | Biopsy | Invasiveness | Deoxyribonucleic acid--DNA | Tumors | Cancer
Journal Article